Results 141 to 150 of about 4,001 (193)

DNM2 lipid binding drives centronuclear myopathy and represents a potential therapeutic target. [PDF]

JCI Insight
Gómez-Oca R, Massana-Muñoz X, Reiss D, De Carvalho Neves J, Diedhiou N, Silva-Rojas R, Cowling BS, Goret M, Laporte J.   +8 more
europepmc   +1 more source

Muscle-specific increased expression of <i>JAG1</i> improves the skeletal muscle phenotype in dystrophin-deficient mice. [PDF]

Proc Natl Acad Sci U S A
de Souza Leite F, Lambert MR, Zhang TY, Conner JR, Paulo JA, Oliveira SF, Guha Thakurta S, Bowles J, Gussoni E, Gygi SP, Widrick JJ, Kunkel LM.   +11 more
europepmc   +1 more source

Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle. [PDF]

Am J Physiol Cell Physiol
Chen HY, Michele DE.
europepmc   +1 more source

TMEM259/MEMBRALIN is a non-canonical ER-phagy receptor that associates with MAN1B1 and VCP to eliminate viral glycoproteins. [PDF]

Autophagy Rep
Camilleri JM, Zhang J, Wang T, Ahmad I, Li S, Zheng YH.   +5 more
europepmc   +1 more source

Exploring Dystrophin Expression and Mutations in the <i>DMD</i> and Dystrophin-Glycoprotein Complex Genes as Prognostic Factors in Leiomyosarcomas. [PDF]

Int J Mol Sci
Salazar J, Cerdà P, Artigas A, Orellana R, González A, Terés R, Arranz MJ, Bagué S, Fumagalli C, González JA, Peiró A, González-Quereda L, Rodríguez MJ, Gallardo E, Aguado M, Sebio A.   +15 more
europepmc   +1 more source

Analysis of Exon Skipping Applicability for Dysferlinopathies. [PDF]

Cells
Leckie J, Rodriguez SH, Krahn M, Yokota T, Yokota T.   +4 more
europepmc   +1 more source

A Trichomonas vaginalis C2-XYPPX-repeat protein with a structured C2 domain displaying dampened flexibility upon binding calcium. [PDF]

Biochimie
Buchko GW, Liu L, Battaile KP, Craig JK, Harmon EK, Van Voorhis WC, Myler PJ, Lovell S.   +7 more
europepmc   +1 more source

Untangling Complexity in Dysferlinopathy With MRI Modeling of Disease Trajectory. [PDF]

Neurol Genet
Morrow JM.
europepmc   +1 more source

Plasma membrane repair defect in Alzheimer's disease neurons is driven by the reduced dysferlin expression. [PDF]

FASEB J
Bulgart HR, Lopez Perez MA, Tucker A, Giarrano GN, Banford K, Miller O, Bonser SWG, Wold LE, Scharre D, Weisleder N.   +9 more
europepmc   +1 more source

Identification of prognostic biomarkers in a large cohort of patients with LGMD R2. [PDF]

J Neurol
Bolano-Diaz CF, Verdu-Diaz J, Hao D, James MK, Rufibach L, Blamire A, Reyngoudt H, Carlier PG, Gordish-Dressman H, Hilsden H, Spuler S, Day J, Jones KJ, Bharucha-Goebel D, Pestronk A, Walter MC, Paradas C, Stojkovic T, Mori-Yoshimura M, Bravver E, Pegoraro E, Mendell J, Jain COS Consortium, Straub V, Diaz-Manera J.   +24 more
europepmc   +1 more source